| |
| |
|
| Insider
Information: |
Schuth Alexander O. |
| Relationship: |
COFO and Secretary |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
187,341 |
|
|
Indirect Shares
|
523,749 |
|
|
| Direct
Value |
$3,743,073 |
|
|
|
Indirect Value
|
$10,464,505 |
|
|
| Total
Shares |
711,090 |
|
|
| Total
Value |
$14,207,578 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
15
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
13
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -40.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Denali Therapeutics Inc. |
DNLI |
COFO and Secretary |
2024-02-14 |
187,341 |
2024-02-14 |
523,749 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
90 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-08-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,643 |
22,685 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2020-02-07 |
4/A |
OE |
$0.00 |
$0 |
D/D |
4,250 |
30,089 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2020-08-20 |
4 |
OE |
$0.00 |
$0 |
I/I |
5,643 |
616,516 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2021-02-07 |
4 |
OE |
$0.00 |
$0 |
I/I |
4,250 |
538,812 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
31,000 |
117,454 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2022-08-09 |
4 |
A |
$0.00 |
$0 |
D/D |
22,500 |
121,458 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
41,120 |
157,578 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2024-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
53,720 |
170,157 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2021-09-20 |
4 |
OE |
$0.68 |
$6,151 |
D/D |
9,045 |
95,499 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2022-10-07 |
4 |
OE |
$0.68 |
$13,600 |
I/I |
20,000 |
487,471 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-02-13 |
4 |
OE |
$0.68 |
$17,000 |
I/I |
25,000 |
524,902 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2024-02-08 |
4 |
OE |
$0.68 |
$34,000 |
D/D |
50,000 |
210,185 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2018-06-22 |
4 |
OE |
$5.28 |
$31,247 |
D/D |
5,918 |
5,918 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2018-10-02 |
4 |
OE |
$5.28 |
$62,498 |
D/D |
7,043 |
12,961 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-10-23 |
4 |
OE |
$5.28 |
$27,081 |
D/D |
5,129 |
25,839 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-12-03 |
4 |
OE |
$5.28 |
$3,754 |
D/D |
711 |
26,550 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-12-04 |
4 |
OE |
$5.28 |
$16,479 |
D/D |
3,121 |
28,960 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-01-17 |
4 |
OE |
$5.28 |
$52,800 |
I/I |
10,000 |
507,173 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-04-12 |
4 |
OE |
$5.28 |
$26,939 |
I/I |
5,102 |
533,793 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-04-13 |
4 |
OE |
$5.28 |
$25,861 |
I/I |
4,898 |
533,589 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-05-15 |
4 |
OE |
$5.28 |
$52,800 |
I/I |
10,000 |
538,691 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-07-17 |
4 |
OE |
$5.28 |
$52,800 |
I/I |
10,000 |
538,691 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2024-02-13 |
4 |
AS |
$17.29 |
$46,960 |
D/D |
(2,716) |
207,469 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2024-02-14 |
4 |
AS |
$17.66 |
$355,460 |
D/D |
(20,128) |
187,341 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-11-22 |
4 |
AS |
$18.00 |
$11,628 |
I/I |
(646) |
598,732 |
0 |
- |
|
90 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
